All Vendors
Diazyme logo
Specialty Chemistry

Diazyme

Specialty chemistry assays that fill critical testing gaps

Diazyme Laboratories develops specialty chemistry assays that address underserved testing needs on open-platform analyzers. Their portfolio includes high-sensitivity CRP, cystatin C, homocysteine, 1,5-AG (GlycoMark equivalent), direct enzymatic HbA1c, and other specialty analytes that are difficult to source for Caribbean laboratories running open-platform chemistry systems. Diazyme assays are FDA-cleared and validated on major analyzer platforms.

5

Products

2

Product Families

3

Sectors Served

Product Portfolio

Specialty Chemistry Assays

Advanced chemistry tests for cardiovascular risk, kidney function, and diabetes monitoring.

hs-CRP (High-Sensitivity C-Reactive Protein)

Specialty Chemistry

Latex-enhanced immunoturbidimetric hsCRP for cardiovascular risk assessment. FDA-cleared, AHA/CDC guideline compliant. Open-platform compatible.

  • Latex immunoturbidimetric
  • FDA cleared
  • AHA/CDC compliant
  • Open platform

Cystatin C

Specialty Chemistry

Particle-enhanced immunoturbidimetric cystatin C for eGFR estimation. Superior to creatinine-based GFR in pediatric, elderly, and muscle-wasting patients.

  • Particle-enhanced immunoturbidimetric
  • eGFR estimation
  • IFCC standardized
  • Open platform

Homocysteine

Specialty Chemistry

Enzymatic homocysteine assay for cardiovascular risk assessment and folate/B12 deficiency screening. No sample pretreatment required.

  • Enzymatic method
  • No pretreatment
  • Cardiovascular risk
  • Open platform

1,5-Anhydroglucitol (1,5-AG)

Specialty Chemistry

Enzymatic 1,5-AG assay for glycemic variability monitoring in diabetes. Complements HbA1c by detecting postprandial glucose excursions. GlycoMark equivalent.

  • Glycemic variability marker
  • Complements HbA1c
  • Detects glucose spikes
  • Enzymatic method

Enzymatic HbA1c & Diabetes

Direct enzymatic HbA1c and advanced diabetes monitoring assays.

Enzymatic HbA1c

Specialty Chemistry

Direct enzymatic HbA1c assay for open-platform chemistry analyzers. No hemoglobin variant interference — ideal for Caribbean populations with high sickle cell trait prevalence.

  • Direct enzymatic method
  • No Hb variant interference
  • NGSP certified
  • Ideal for sickle cell populations

Applications

  • Cardiovascular risk assessment
  • Kidney function monitoring
  • Diabetes management
  • Specialty chemistry
  • Open-platform testing

Sectors Served

Clinical LaboratoryHospitalEndocrinology Clinic

Interested in Diazyme?

Contact us for pricing, product availability, and technical support for Diazyme products in your territory.